drugset

drugset / Trial / NCT06173999

A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma

NCT06173999 ↗

Phase 1/2 Unknown 100 enrolled Jiangsu HengRui Medicine Co., Ltd.

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The study is being conducted to evaluate the safety and efficacy of SHR2554 with CHOP/CHOEP in treatment- naïve peripheral T-cell lymphoma.

Timeline

Start: 2023-12-22
Primary completion: 2025-12-31
Completion: 2025-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SHR2554	Small molecule	—	—

Indications